These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11412657)

  • 21. Long-term oral anticoagulant therapy in patients with unstable angina or suspected non-Q-wave myocardial infarction.
    Ferguson JJ
    Circulation; 1999 Jun; 99(22):2968. PubMed ID: 10359749
    [No Abstract]   [Full Text] [Related]  

  • 22. New frontiers in the management of unstable coronary artery disease.
    Turpie AG
    Am J Cardiol; 1997 Sep; 80(5A):21E-24E. PubMed ID: 9296465
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Low molecular weight heparin in unstable angina].
    Kher A; Samama MM
    Arch Mal Coeur Vaiss; 1996 Nov; 89(11 Suppl):1495-500. PubMed ID: 9092409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beyond heparin and aspirin: new treatments for unstable angina and non-Q-wave myocardial infarction.
    Weitz JI; Bates SM
    Arch Intern Med; 2000 Mar; 160(6):749-58. PubMed ID: 10737274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low-molecular weight heparins.
    Talley JD
    J Ark Med Soc; 1997 Apr; 93(11):555-6. PubMed ID: 9114648
    [No Abstract]   [Full Text] [Related]  

  • 26. Evaluating the place of low-molecular-weight heparin in the management of acute coronary syndromes. A panel discussion with audience participation.
    Chesebro JH; Verheugt FW; Kontny F; Fry ET; Wallentin L; Camm AJ; Bechtold H
    Clin Cardiol; 2001 Mar; 24(3 Suppl):I20-2. PubMed ID: 11286311
    [No Abstract]   [Full Text] [Related]  

  • 27. New therapies for unstable angina and non-Q-wave myocardial infarction: recent clinical trials.
    Cohen M
    Am Heart J; 1998 Jun; 135(6 Pt 3 Su):S343-52. PubMed ID: 9628448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Role of low-molecular-weight heparin in acute coronary syndromes].
    Gharbi M; Barakett N; Lahidheb DH; Smiri Z; Fehri W; Azzouzi F; Rahal N; Mhenni H; Haouala H; Guediche M
    Tunis Med; 2002 Dec; 80(12):725-32. PubMed ID: 12664498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anticoagulants in acute coronary syndromes.
    Turpie AG
    Am J Cardiol; 1999 Sep; 84(5A):2M-6M. PubMed ID: 10505536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of low-molecular-weight heparins in non-ST-segment elevation acute coronary syndromes.
    Nguyen-Ho P; Levine GN
    Panminerva Med; 2002 Jun; 44(2):115-22. PubMed ID: 12032429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low molecular weight heparins for acute coronary syndrome: tackling the issues head-on.
    Antman EM
    Am Heart J; 2003 Aug; 146(2):191-3. PubMed ID: 12891179
    [No Abstract]   [Full Text] [Related]  

  • 32. Efficacy of low-molecular-weight heparin in acute coronary syndromes.
    Wallentin L
    Am Heart J; 2000 Feb; 139(2 Pt 2):S29-32. PubMed ID: 10650313
    [No Abstract]   [Full Text] [Related]  

  • 33. The present and future of heparin, low molecular weight heparins, pentasaccharide, and hirudin for venous thromboembolism and acute coronary syndromes.
    Haas S
    Semin Vasc Med; 2003 May; 3(2):139-46. PubMed ID: 15199477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Approaches to the treatment of unstable angina and non-Q wave myocardial infarction.
    Cohen M
    Can J Cardiol; 1998 Aug; 14 Suppl E():11E-14E. PubMed ID: 9779027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological and clinical evidence for the use of low-molecular-weight heparins in acute coronary syndromes.
    Rosito GA; Silva OB; Ribeiro JP
    Arq Bras Cardiol; 2001 Aug; 77(2):184-95. PubMed ID: 11514830
    [No Abstract]   [Full Text] [Related]  

  • 36. [Use of heparin in unstable angina and non-Q-wave infarction].
    Choussat R; Attali P;
    Arch Mal Coeur Vaiss; 2001 Jan; 94(1):62-70. PubMed ID: 11233483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advances in unstable angina: the role of low molecular weight heparins. Introduction and Chairmen's summary.
    Braunwald E; Gurfinkel E
    Heart; 1999 Sep; 82 Suppl 1(Suppl 1):I1, I21. PubMed ID: 10469668
    [No Abstract]   [Full Text] [Related]  

  • 38. Low-molecular-weight heparins for the treatment of acute coronary syndromes.
    Wong GC; Giugliano RP
    Semin Vasc Med; 2003 Nov; 3(4):391-402. PubMed ID: 15199446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enoxaparin and dalteparin in unstable angina: new indication. Enoxaparin: a reference treatment. Dalteparin: no better than unfractionated heparin.
    Prescrire Int; 1999 Jun; 8(41):77-80. PubMed ID: 10558446
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low molecular weight heparins in acute ischaemic syndromes.
    White HD; Ellis CJ; French JK
    Aust N Z J Med; 1998 Aug; 28(4):555-7. PubMed ID: 9777139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.